The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Items 201–300 of 785
Selkirk, C. G., Vogel, K. J., Newlin, A. C., Weissman, S. M., Weiss, S. M., Wang, C., & Hulick, P. J. (2014) · Familial Cancer · doi:10.1007/s10689-014-9741-4 · Cited by 37
Pancreatic carcinoma: Key-points from diagnosis to treatment
Frampas, É., David, A., Régenet, N., Touchefeu, Y., Meyer, J. F., & Morla, O. (2016) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2016.07.008 · Cited by 37
Cotter, T. G., Burger, K. N., Devens, M. E., Simonson, J. A., Lowrie, K. L., Heigh, R. I., Mahoney, D. W., Johnson, D. H., Ahlquist, D. A., & Kisiel, J. B. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0800 · Cited by 39
Sheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., Raraty, M., Ramesh, J., Farooq, A., Costello, E., et al. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0395-y · Cited by 36
Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival
Ulanja, M. B., Moody, A. E., Beutler, B. D., Antwi‐Amoabeng, D., Rahman, G. A., & Alese, O. B. (2022) · Oncotarget · doi:10.18632/oncotarget.28242 · Cited by 38
Hereditary Pancreatic Cancer Syndromes
Connor, A. A., & Gallinger, S. (2015) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2015.06.007 · Cited by 36
Sereti, E., Karagianellou, T., Kotsoni, I., Magouliotis, D. E., Kamposioras, K. V., Ulukaya, E., Sakellaridis, N., Zacharoulis, D., & DIMAS, K. S. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.01.012 · Cited by 37
Bartsch, D. K., Krasser‐Gercke, N., Strauch, K., Wieboldt, R., Matthäi, E., Wagner, V., Rospleszcz, S., Schäfer, A., Franke, F. S., Mintziras, I., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100295 · Cited by 36
Surveillance for pancreatic cancer in high‐risk individuals
Konings, I. C. A. W., Canto, M. I., Almario, J. A., Harinck, F., Saxena, P., Lucas, A. L., Kastrinos, F., Whitcomb, D. C., Brand, R. E., Lachter, J., et al. (2019) · BJS Open · doi:10.1002/bjs5.50180 · Cited by 36
Self-citationPathogenesis of Pancreatic Cancer
Murtaugh, L. C. (2013) · Toxicologic Pathology · doi:10.1177/0192623313508250 · Cited by 40
Bhutani, M., Cazacu, I. M., Chavez, A. L., & Săftoiu, A. (2018) · Endoscopic Ultrasound · doi:10.4103/eus.eus_25_18 · Cited by 35
Conversion Surgery for Advanced Pancreatic Cancer
Hank, T. P., & Strobel, O. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111945 · Cited by 35
Hereditary Polyposis Syndromes
Kidambi, T. D., Kohli, D. R., Samadder, N. J., & Singh, A. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00251-4 · Cited by 35
Boland, C. R., Idos, G., Durno, C. A., Giardiello, F. M., Anderson, J. C., Burke, C. A., Dominitz, J. A., Gross, S. A., Gupta, S. N., Jacobson, B. C., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001755 · Cited by 36
Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals
Capurso, G. (2015) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v7.i9.833 · Cited by 35
Sadakari, Y., Kanda, M., Maitani, K., Borges, M. W., Canto, M. I., & Goggins, M. (2014) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2014.14 · Cited by 35
Self-citationUrayama, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1707 · Cited by 36
Nesteruk, K., Levink, I. J. M., de Vries, E., Visser, I. J., Peppelenbosch, M. P., Cahen, D. L., Fuhler, G. M., & Bruno, M. J. (2022) · Pancreatology · doi:10.1016/j.pan.2022.04.010 · Cited by 34
Self-citationFamilial Pancreatic Cancer and the Future of Directed Screening
Welinsky, S., & Lucas, A. L. (2017) · Gut and Liver · doi:10.5009/gnl16414 · Cited by 33
The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes
Slavin, T. P., Neuhausen, S. L., Nehoray, B., Niell‐Swiller, M., Solomon, I. B., Rybak, C., Blazer, K. R., Adamson, A. W., Yang, K., Sand, S. R., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-0019-5 · Cited by 33
Li, H., Shi, K., Reichert, M., Lin, K., Tselousov, N., Braren, R., Fu, D., Schmid, R. M., Li, J., & Menze, B. H. (2019) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2019.8856745 · Cited by 33
Kulkarni, N. M., Mannelli, L., Zins, M., Bhosale, P., Arif‐Tiwari, H., Brook, O. R., Hecht, E. M., Kastrinos, F., Wang, Z. J., Soloff, E. V., et al. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02290-y · Cited by 33
Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic
Borecká, M., Zemánková, P., Vočka, M., Souček, P., Soukupová, J., Kleiblová, P., Sevcik, J., Kleibl, Z., & Janatová, M. (2016) · Cancer Genetics · doi:10.1016/j.cancergen.2016.03.003 · Cited by 33
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
Martínez‐Useros, J., & García‐Foncillas, J. (2016) · BioMed Research International · doi:10.1155/2016/4873089 · Cited by 34
Is screening for pancreatic cancer in high-risk individuals one step closer or a fool's errand?
Hart, P. A., & Chari, S. T. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.024 · Cited by 32
Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
Lee, H. S., Jang, C. Y., Kim, S. A., Park, S. B., Jung, D. E., Kim, B. O., Kim, H. Y., Chung, M. J., Park, J. Y., Bang, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21823-x · Cited by 44
Kumar, S., Inigo, J. R., Kumar, R., Chaudhary, A. K., O’Malley, J., Balachandar, S., Wang, J., Attwood, K. M., Yadav, N., Hochwald, S. N., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.029 · Cited by 32
Bekkali, N. L. H., & Oppong, K. (2017) · Endoscopic Ultrasound · doi:10.4103/eus.eus_60_17 · Cited by 35
Zou, J., Chen, S., Li, Y., Zeng, L., Lian, G., Li, J., Chen, S., Huang, K., & Chen, Y. (2020) · Nanoscale · doi:10.1039/c9nr04976b · Cited by 32
Surveillance of high-risk individuals for pancreatic cancer with EUS and MRI: A meta-analysis
Kogekar, N., Diaz, K. E., Weinberg, A. D., & Lucas, A. L. (2020) · Pancreatology · doi:10.1016/j.pan.2020.10.025 · Cited by 35
Gallo, M., Adinolfi, V., Morviducci, L., Acquati, S., Tuveri, E., Ferrari, P., Zatelli, M. C., Faggiano, A., Argentiero, A., Natalicchio, A., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100155 · Cited by 33
Jang, K. M., Kim, S. H., Kim, Y. K., Song, K. D., Lee, S. J., & Choi, D. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.05.012 · Cited by 31
Screening and Surgical Outcomes of Familial Pancreatic Cancer
Templeton, A. W., & Brentnall, T. A. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.02.002 · Cited by 31
Clinical Management of Pancreatic Cancer
Reynolds, R. B., & Folloder, J. P. (2014) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2014.5.5.6 · Cited by 31
Sheth, S. G., Conwell, D. L., Whitcomb, D. C., Alsante, M., Anderson, M. A., Barkin, J. S., Brand, R. E., Coté, G. A., Freedman, S. D., Gelrud, A., et al. (2017) · Pancreatology · doi:10.1016/j.pan.2017.02.015 · Cited by 31
Lindquist, C. M., Miller, F. H., Hammond, N., & Nikolaidis, P. (2018) · Abdominal Radiology · doi:10.1007/s00261-017-1308-z · Cited by 4
Circadian Genes as Therapeutic Targets in Pancreatic Cancer
García-Costela, M., Escudero-Feliú, J., Puentes-Pardo, J. D., Moreno-SanJuan, S., Morales, S., Ríos‐Arrabal, S., Carazo, Á., & León, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00638 · Cited by 32
Prediction Model for Pancreatic Cancer—A Population-Based Study from NHIRD
Lee, H.-A., Chen, K., & Hsu, C. (2022) · Cancers · doi:10.3390/cancers14040882 · Cited by 30
Screening for Pancreatic Cancer
Ngamruengphong, S., & Canto, M. I. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.07.016 · Cited by 30
Self-citationKim, J., Yuan, C., Babić, A., Bao, Y., Clish, C. B., Pollak, M., Amundadottir, L. T., Klein, A. P., Stolzenberg‐Solomon, R. Z., Pandharipande, P. V., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-1389 · Cited by 29
Shariq, O. A., Lines, K. E., English, K. A., Jafar‐Mohammadi, B., Prentice, P. M., Casey, R. T., Challis, B., Selberherr, A., Boon, H., Cranston, T., et al. (2021) · Surgery · doi:10.1016/j.surg.2021.04.041 · Cited by 30
Calderwood, A. H., Sawhney, M., Thosani, N. C., Rebbeck, T. R., Wani, S. B., Canto, M. I., Fishman, D. S., Golan, T., Hidalgo, M. M., Kwon, R. S., et al. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2021.12.002 · Cited by 30
Self-citationRosenthal, E. T., Evans, B. A., Kidd, J., Brown, K. L., Gorringe, H., van Orman, M., & Manley, S. (2016) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2016.10.003 · Cited by 30
Screening in GI Cancers: The Role of Genetics
Stoffel, E. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.6764 · Cited by 30
Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
Roch, A. M., Schneider, J., Carr, R. A., Lancaster, W. P., House, M. G., Zyromski, N. J., Nakeeb, A., Schmidt, C. M., & Ceppa, E. P. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25376 · Cited by 29
New developments in the early diagnosis of pancreatic cancer
Zhang, Q., Chen, S., Zeng, L., Chen, Y., Lian, G., Qian, C., Li, J., Xie, R., & Huang, K. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1271323 · Cited by 29
Moutinho-Ribeiro, P., Iglesias-Garcia, J., Gaspar, R., & Macedo, G. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.027 · Cited by 29
Pang, Y., Holmes, M. V., Chen, Z., & Kartsonaki, C. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14576 · Cited by 30
Peretti, U., Cavaliere, A., Niger, M., Tortora, G., Marco, M. D., Rodriquenz, M. G., Centonze, F., Rapposelli, I. G., Giordano, G., Vita, F. D., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2020.100032 · Cited by 29
Vietri, M. T., D’Elia, G., Caliendo, G., Albanese, L., Signoriello, G., Claudio Napoli, A., & Molinari, A. M. (2022) · Genes · doi:10.3390/genes13020321 · Cited by 29
Surveillance for neoplasia in the pancreas
Overbeek, K. A., Cahen, D. L., Canto, M. I., & Bruno, M. J. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.10.013 · Cited by 28
Self-citationHigh-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening
Bruenderman, E. H., & Martin, R. C. G. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.06.046 · Cited by 28
Pancreatitis and Pancreatic Cancer
Walling, A. D., & Freelove, R. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.07.004 · Cited by 29
A Review of Pancreatic Cancer: Epidemiology, Genetics, Screening, and Management
Idachaba, S., Dada, O., Abimbola, O., Olayinka, O., Uma, A., Olunu, E., & Fakoya, A. O. J. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.104 · Cited by 28
Management of breast cancer risk inBRCA1/2mutation carriers who are unaffected with cancer
Collins, J. M., & Isaacs, C. J. (2020) · The Breast Journal · doi:10.1111/tbj.13970 · Cited by 28
Santos, R. J., Coleman, H. G., Cairnduff, V., & Kunzmann, A. T. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002022 · Cited by 29
Development of a high risk pancreatic screening clinic using 3.0 T MRI
Barnes, C. A., Krzywda, E. A., Lahiff, S., McDowell, D., Christians, K. K., Knechtges, P., Tolat, P. P., Hohenwalter, M. D., Dua, K. S., Khan, A. H., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-0057-z · Cited by 28
Clinical features and management of BRCA1 and BRCA2-associated prostate cancer.
Alanee, S., Glogowski, E., Schrader, K., Eastham, J., & Offit, K. (2014) · Frontiers in Bioscience · doi:10.2741/e686 · Cited by 24
Familial Pancreatic Ductal Adenocarcinoma.
Diaz, K., & Lucas, A. (2019) · American Journal of Pathology · doi:10.1016/j.ajpath.2018.06.026 · Cited by 24
Goverde, A., Eikenboom, E. L., Viskil, E. L., Bruno, M. J., Doukas, M., Dinjens, W. N. M., Dubbink, H. J., van den Ouweland, A. M. W., Hofstra, R. M. W., Wagner, A., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.043 · Cited by 27
Self-citationHanna-Sawires, R. G., Schiphuis, J. H., Wuhrer, M., Vasen, H. F. A., van Leerdam, M. E., Bonsing, B. A., Mesker, W. E., van der Burgt, Y. E. M., & Tollenaar, R. A. �. �. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052655 · Cited by 27
Seufferlein, T. T. W., Mayerle, J. V., Böck, S., Brunner, T. B., Ettrich, T. J., Grenacher, L., Gress, T. M., Hackert, T., Heinemann, V., Kestler, A. M. R., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1856-7346 · Cited by 29
Endoscopic Ultrasound–Based Pancreatic Cancer Screening of High-Risk Individuals
Gangi, A., Malafa, M. P., & Klapman, J. B. (2018) · Pancreas · doi:10.1097/mpa.0000000000001038 · Cited by 27
Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma
Thiruvengadam, S. S., Chuang, J., Huang, R. J., Girotra, M., & Park, W. G. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.029 · Cited by 26
Jacobson, S., Dahlqvist, P. M., Johansson, M., Svensson, J., Billing, O., Sund, M., & Franklin, O. (2021) · Pancreatology · doi:10.1016/j.pan.2021.05.008 · Cited by 26
Asymptomatic pancreatic cancer: does incidental detection impact long-term outcomes?
Takeda, Y., Saiura, A., Takahashi, Y., Inoue, Y., Ishizawa, T., Mise, Y., Matsumura, M., Ichida, H., Matsuki, R., Tanaka, M., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3421-2 · Cited by 27
Pancreatic Adenocarcinoma: Improving Prevention and Survivorship
Sohal, D. P. S., Willingham, F. F., Falconi, M., Raphael, K. L., & Crippa, S. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175222 · Cited by 26
Avril, M.-F., Bahadoran, P., Cabaret, O., Caron, O., de la Fouchardière, A., Démenais, F., Desjardins, L., Frébourg, T., Hammel, P. R., Leccia, M. ‐., et al. (2014) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2014.09.606 · Cited by 25
Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies
Raoof, S., Lee, R. J., Jajoo, K., Mancias, J. D., Rebbeck, T. R., & Skates, S. J. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-1443 · Cited by 26
Lynch syndrome: from detection to treatment
Williams, M. H., Hadjinicolaou, A. V., Norton, B. C., Kader, R., & Lovat, L. B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1166238 · Cited by 26
Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer
Lami, G. (2014) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v6.i7.272 · Cited by 25
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma
Reznik, R. S., Hendifar, A. E., & Tuli, R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00087 · Cited by 25
Maire, F., Cibot, J.-O., Compagne, C., Hentic, O., Hammel, P. R., Müller, N., Ponsot, P., Lévy, P., & Ruszniewski, P. B. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000901 · Cited by 25
Detecting Early Pancreatic Cancer: Current Problems and Future Prospects
Matsubayashi, H., Ishiwatari, H., Sasaki, K., Uesaka, K., & Ono, H. (2019) · Gut and Liver · doi:10.5009/gnl18491 · Cited by 24
Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging
Morani, A. C., Hanafy, A. K., Ramani, N. S., Katabathina, V. S., Yedururi, S., Dasyam, A. K., & Prasad, S. R. (2020) · Radiology Imaging Cancer · doi:10.1148/rycan.2020190020 · Cited by 24
Capurso, G., Paiella, S., Carrara, S., Butturini, G., Secchettin, E., Frulloni, L., Zerbi, A., & Falconi, M. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.07.027 · Cited by 24
Breath analysis for the detection of digestive tract malignancies: systematic review
Hintzen, K. F. H., Grote, J., Wintjens, A. G. W. E., Lubbers, T., Eussen, M. M. M., van Schooten, F., Bouvy, N. D., & Peeters, A. (2021) · BJS Open · doi:10.1093/bjsopen/zrab013 · Cited by 25
The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
Levink, I. J. M., Jaarsma, S. C., Koopmann, B. D. M., van Riet, P. A., Overbeek, K. A., Meziani, J., Sprij, M. L. J. A., Casadei, R., Ingaldi, C., Polkowski, M., et al. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12422 · Cited by 23
Self-citationFamilial Pancreatic Cancer and Surveillance of High-Risk Individuals
Matsubayashi, H., Takaori, K., Morizane, C., & Kiyozumi, Y. (2019) · Gut and Liver · doi:10.5009/gnl18449 · Cited by 24
Technological advances for the detection of melanoma
Fried, L., Tan, A., Bajaj, S., Liebman, T. N., Polsky, D., & Stein, J. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.03.122 · Cited by 24
The impact of a history of cancer on pancreatic ductal adenocarcinoma survival
He, X., Li, Y., Su, T., Lai, S., Wu, W., Chen, L., Si, J., & Sun, L. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618765505 · Cited by 23
Vullierme, M., Menassa, L., Couvelard, A., Rebours, V., Maire, F., Ibrahim, T., Cros, J. F., Ruszniewski, P. B., Sauvanet, A., Lévy, P., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06154-3 · Cited by 23
Macgregor-Das, A. M., Yu, J., Tamura, K., Abe, T., Suenaga, M., Shindo, K., Borges, M. W., Koi, C., Kohi, S., Sadakari, Y., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.02.010 · Cited by 25
Self-citationKimura, H., Paranal, R. M., Nanda, N., Wood, L. D., Eshleman, J. R., Hruban, R. H., Goggins, M. G., Klein, A. P., The Familial Pancreatic Cancer Genome Sequencing Project, & Roberts, N. J. (2022) · eLife · doi:10.7554/elife.71137 · Cited by 23
Self-citationBestari, M. B., Joewono, I. R., & Syam, A. F. (2024) · Biomolecules · doi:10.3390/biom14030364 · Cited by 24
The role of biomarkers in the early detection of pancreatic cancer
Goggins, M. (2024) · Familial Cancer · doi:10.1007/s10689-024-00381-4 · Cited by 28
Self-citationTurpin, A., Cattan, S., Leclerc, J., Wacrenier, A., Manouvrier‐Hanu, S., Buisine, M., & Lejeune‐Dumoulin, S. (2014) · Bulletin du Cancer · doi:10.1684/bdc.2014.1942 · Cited by 23
Imaging and Screening of Pancreatic Cancer
Burk, K. S., Lo, G. C., Gee, M. S., & Sahani, D. V. (2017) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2017.06.006 · Cited by 23
Hata, T., Molin, M. D., McGregor-Das, A., Song, T. J., Wolfgang, C. L., Eshleman, J. R., Hruban, R. H., & Goggins, M. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.09.006 · Cited by 23
Self-citationLorenzo, D., Rebours, V., Maire, F., Palazzo, M., Gonzalez, J., Vullierme, M., Aubert, A., Hammel, P. R., Lévy, P., & de Mestier, L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5082 · Cited by 25
Hüneburg, R., Aretz, S., Büttner, R., Daum, S., Engel, C., Fechner, G., Habermann, J. K., Heling, D., Hoffmann, K., Holinski‐Feder, E., et al. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1008-9827 · Cited by 23
Vareedayah, A. A., Alkaade, S., & Taylor, J. R. (2013) · Thieme eBooks · doi:10.1055/b-0034-78958 · Cited by 23
Quality assessment of the guidelines on cystic neoplasms of the pancreas
Falconi, M., Crippa, S., Chari, S. T., Conlon, K. C., Kim, S., Lévy, P., Tanaka, M., Werner, J., Wolfgang, C. L., Pezzilli, R., et al. (2015) · Pancreatology · doi:10.1016/j.pan.2015.05.478 · Cited by 22
Intraductal Papillary Mucinous Neoplasms in Hereditary Cancer Syndromes
Ardeshna, D. R., Rangwani, S. M., Cao, T., Pawlik, T. M., Stanich, P. P., & Krishna, S. G. (2022) · Biomedicines · doi:10.3390/biomedicines10071475 · Cited by 24
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
Casolino, R., Corbo, V., Beer, P. A., Hwang, C., Paiella, S., Silvestri, V., Ottini, L., & Biankin, A. V. (2022) · Cancers · doi:10.3390/cancers14133239 · Cited by 24
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
Koltai, T. (2023) · Cancers · doi:10.3390/cancers15184430 · Cited by 22
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer
Paiella, S., Capurso, G., Carrara, S., Secchettin, E., Casciani, F., Frigerio, I. M., Zerbi, A., Archibugi, L., Bonifacio, C., Malleo, G., et al. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002546 · Cited by 22
Self-citationRastegar, N., Matteoni-Athayde, L. G., Eng, J., Takahashi, N., Tamm, E. P., Mortelé, K. J., Syngal, S., Margolis, D., Lennon, A. M., Wolfgang, C. L., et al. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.12.028 · Cited by 22
Self-citationPancreatic Cancer Chemoprevention Translational Workshop
Miller, M. S., Allen, P., Brentnall, T. A., Goggins, M., Hruban, R. H., Petersen, G. M., Rao, C. V., Whitcomb, D. C., Brand, R. E., Chari, S. T., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000705 · Cited by 23
Self-citationPancreatic ductal adenocarcinoma in BRCA2 mutation carriers
de Mestier, L., Danset, J. B., Neuzillet, C., Rebours, V., Cros, J. F., Soufir, N., & Hammel, P. R. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0269 · Cited by 23
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
